Sarla Performance Fibers down 6.5% on softer Q2 PAT and ESOP overhang

On a standalone basis, Sarla Performance Fibers reported:

• Revenue from operations of Rs 112.33 cr for the quarter ended September 30, 2026 (page 9).
• Other income of Rs 3.40 cr, taking total income to Rs 115.73 cr.
• Total expenses of Rs 103.73 cr.
• Profit before tax of Rs 12.00 cr.
• Profit after tax of Rs 12.00 cr ("Profit after tax" on page 9).

On a consolidated basis, the company reported (page 9):

• Revenue from operations of Rs 119.88 cr for the quarter.
• Other income of Rs (2.49) cr, leading to total income of Rs 117.40 cr.
• Total expenses of Rs 105.33 cr.
• Profit before tax of Rs 12.07 cr.
• Profit after tax of Rs 11.50 cr.

For the half year ended September 30, 2026, consolidated revenue from operations stood at Rs 233.15 cr, with profit after tax of Rs 48.79 cr (page 9).

The filing presents year‑ago and previous‑quarter comparatives in the same table, but it does not compute or discuss margins. Where investors are concerned about profitability trends, they are therefore looking at the movement in profit before tax and profit after tax rather than any reported margin percentage.

The company flagged specific headwinds in its notes (page 9):

• “Ongoing geopolitical tensions in the Middle East led to higher freight and raw material costs during the quarter ended September 30, 2026.”
• “In addition, the Company incurred a one-time flood-related loss of ~2.31 cr at its Silvassa plant.”

That flood‑related loss is also reflected in the consolidated cash flow statement as a "Loss due to flood" of Rs 2.31 cr (page 12). These items likely contributed to the pressure on quarterly profitability and have been picked up by the market as non‑trivial drags on earnings quality.

Beyond the numbers, the other clear focus for traders has been the new employee stock option plan.

The board has approved adoption of the SPFL ESOP Plan 2026, subject to shareholder approval via postal ballot (pages 1–3 and Annexure B):

• A common pool of 39,75,150 options, each convertible into one equity share of face value Rs 1 (page 15).
• Implementation through the SPFL ESOP Trust via secondary acquisition only – no fresh issue is authorised under this scheme (pages 1–2 and 15).
• No options have been granted yet; the filing repeatedly notes "No Options have been granted at this Board Meeting" and "Nil" for options granted, vested or exercised (pages 3, 15–17).

Crucially for near‑term earnings, the company has also sought shareholder approval to fund the ESOP Trust (page 2):

• Provision of money to the SPFL ESOP Trust, “from time to time and in one or more tranches, solely for Secondary Acquisition of existing equity shares of the Company for implementation of the Scheme and charges directly incidental to such acquisition.”
• The proposed loan is “interest-free, unsecured and co-terminus with the Scheme, with recourse limited to the assets of the Trust.”
• The value of shares to be purchased together with the money provided “shall not exceed 5% of the aggregate of paid-up capital and free reserves under Rule 16(1)(d), computed from time to time.”
• The company will separately bear the costs of establishing and administering the scheme and the trust, including trustee fees.

Even though the scheme uses secondary acquisition (so it does not immediately increase share count), the market typically treats such a large option pool and interest‑free funding to a trust as an overhang on future EPS and a signal that some cash flows will be directed towards buying stock for employees rather than core operations or shareholders.

Auditors have again highlighted legacy regulatory items around a subsidiary (pages 4–5 and 7–8):

• The company sold 11.1% Non‑Cumulative Redeemable Preference Shares in its wholly owned subsidiary Sarlaflex Inc. during the quarter ended March 31, 2026.
• As per Note 2 (page 9), “The sale consideration was credited to the Company's bank account during the quarter ended September 30, 2026. However, the transaction continues to be pending before the regulator for necessary ratification. The Company is pursuing the matter through its Authorised Dealer for completion of the requisite regulatory formalities.”

The consolidated review report (pages 4–5) also points out that:

• Sarlaflex Inc.’s interim financial results are prepared on a going‑concern basis despite suspension of manufacturing operations since December 2017 and negative net worth.
• Investments by Sarla Overseas Holdings Limited in three joint ventures are not consolidated due to disputes or non‑receipt of financials; the auditors state they are “unable to comment about impact of the same on the Unaudited Consolidated Financial results,” though impairment provisions were made in FY 2017‑18.

These disclosures do not introduce new cash outflows in the quarter, but they reinforce a regulatory and subsidiary‑risk overhang that investors must factor into valuations.

Putting it together, the 6.5% slide in Sarla Performance Fibers, with the stock changing hands at Rs 88.40, appears to reflect a combination of:

• A weaker quarterly profit profile versus what the market had been pricing in, even though the filing itself does not comment on expectations.
• Explicit disclosure of higher freight and raw material costs and a one‑time flood loss of ~2.31 cr at Silvassa, which hit Q2 earnings.
• A large ESOP pool of 39,75,150 options and an interest‑free loan to the ESOP Trust, which together raise concerns about future dilution and the use of balance‑sheet resources.
• Continuing regulatory and subsidiary uncertainties around Sarlaflex Inc. and certain joint ventures, as highlighted by the auditors.

The filing does not provide forward guidance, margin commentary or management’s qualitative outlook. In the absence of that, the market reaction has centred on the visible squeeze on profitability, the explicit one‑offs, and the fresh ESOP‑related overhang, leading to profit‑taking in a small‑cap name where such developments can move the stock sharply.